SCHEMBL4701739

SCHEMBL4701739

COc1ccc(CCNC(=O)C=Cc2ccccn2)cc1S(N)(=O)=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.55
MAPT P10636 5/20 0.55
ALDH1A1 P00352 5/20 0.52
KDM4E B2RXH2 4/20 0.52
PKM P14618 1/20 0.52
MAOA P21397 1/20 0.51
MAOB P27338 1/20 0.51
NPC1 O15118 1/20 0.51
RAB9A P51151 1/20 0.51
ALOX5 P09917 1/20 0.50
LMNA P02545 2/20 0.49
HPGD P15428 2/20 0.49
MEN1 O00255 1/20 0.49
HTT P42858 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
TYR P14679 1/20 0.48
ACHE P22303 1/20 0.48
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA7 P43166 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4701732 1.00 KMT2A (0.55) KMT2AMAPTALDH1A1KDM4EPKM
SCHEMBL4702189 0.91 KMT2A (0.48) KMT2AMAPTALDH1A1KDM4EPKM
SCHEMBL4702198 0.91 KMT2A (0.48) KMT2AMAPTALDH1A1KDM4EPKM
SCHEMBL7111646 0.86 MAPT (0.74) KMT2AMAPTALDH1A1KDM4EPKM
SCHEMBL7111643 0.86 MAPT (0.74) KMT2AMAPTALDH1A1KDM4EPKM
SCHEMBL4702222 0.85 ABCC9 (0.58) KMT2AMAPTALDH1A1KDM4EPKM
SCHEMBL4702227 0.85 ABCC9 (0.58) KMT2AMAPTALDH1A1KDM4EPKM
SCHEMBL4702225 0.84 KMT2A (0.49) KMT2AMAPTALDH1A1KDM4EPKM
SCHEMBL4704472 0.81 POLB (0.58) KMT2AMAPTALDH1A1KDM4EPKM
SCHEMBL4704467 0.81 POLB (0.58) KMT2AMAPTALDH1A1KDM4EPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1335902-B1 HETEROARYLACRYLOYLAMINOALKYL-SUBSTITUTED BENZENESULFONAMIDE DERIVATIVES, THEIR PREPARATION, THEIR USE AND PHARMACEUTICAL PREPARATIONS COMPRISING THEM SANOFI AVENTIS DEUTSCHLAND (DE) 2008-10-08 EP disclosed
US-20020123495-A1 Heteroarylacryloylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical preparations comprising them SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2002-09-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020123495-A1 Heteroarylacryloylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical preparations comprising them KCNJ11, HCN3, CACNA1E KMT2A 2851/4885MAPT 4881/4885ALDH1A1 2718/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.